Samit Hirawat
CIK 1781290 · View on SEC EDGAR ↗
First SEC filing: June 12, 2026 · Latest: June 12, 2026
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| April 25, 2025 | BMY | P | 4,250 | $47.58 | $202,215 | 83,513 Direct | +5.36% | Acquired | 40.4% (price as of 2026-08-20) |
| Feb. 14, 2025 | BMY | P | 1,823 | $54.84 | $99,973 | 63,932 Direct | +2.94% | Acquired | 21.8% (price as of 2026-08-20) |
| Nov. 1, 2024 | BMY | P | 1,830 | $54.68 | $100,064 | 62,109 Direct | +3.04% | Acquired | 22.1% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 10, 2026 | PCRX | Stock Option (Right to Buy) | Common Stock (10,891) | $23.42 | June 10, 2036 | 10,891 | Acquired |
| March 10, 2025 | BMY | Performance Shares | Common Stock, $0.10 par value (52,720) | — | March 10, 2028 | 52,720 | Acquired |
| March 10, 2025 | BMY | Performance Shares | Common Stock, $0.10 par value (28,593) | — | March 10, 2025 | 28,593 | Disposed |
| March 10, 2025 | BMY | Market Share Units | Common Stock, $0.10 par value (35,146) | — | March 10, 2028 | 35,146 | Acquired |
| March 10, 2025 | BMY | Market Share Units | Common Stock, $0.10 par value (5,854) | — | March 10, 2027 | 5,854 | Disposed |
| March 10, 2025 | BMY | Market Share Units | Common Stock, $0.10 par value (4,765) | — | March 10, 2026 | 4,765 | Disposed |
| March 10, 2025 | BMY | Market Share Units | Common Stock, $0.10 par value (4,886) | — | March 10, 2025 | 4,886 | Disposed |
| March 10, 2024 | BMY | Performance Shares | Common Stock, $0.10 par value (60,952) | — | March 10, 2027 | 60,952 | Acquired |
| March 10, 2024 | BMY | Performance Shares | Common Stock, $0.10 par value (29,311) | — | March 10, 2024 | 29,311 | Disposed |
| March 10, 2024 | BMY | Market Share Units | Common Stock, $0.10 par value (40,635) | — | March 10, 2028 | 40,635 | Acquired |
| March 10, 2024 | BMY | Market Share Units | Common Stock, $0.10 par value (5,854) | — | March 10, 2027 | 5,854 | Disposed |
| March 10, 2024 | BMY | Market Share Units | Common Stock, $0.10 par value (4,765) | — | March 10, 2026 | 4,765 | Disposed |
| March 10, 2024 | BMY | Market Share Units | Common Stock, $0.10 par value (4,885) | — | March 10, 2025 | 4,885 | Disposed |
| March 10, 2024 | BMY | Market Share Units | Common Stock, $0.10 par value (4,192) | — | March 10, 2024 | 4,192 | Disposed |
| July 1, 2023 | BMY | Restricted Stock Units | Common Stock, $0.10 par value (9,357) | — | July 1, 2023 | 9,357 | Disposed |
| March 10, 2023 | BMY | Performance Shares | Common Stock, $0.10 par value (35,129) | — | March 10, 2026 | 35,129 | Acquired |
| March 10, 2023 | BMY | Performance Shares | Common Stock, $0.10 par value (25,139) | — | March 10, 2023 | 25,139 | Disposed |
| March 10, 2023 | BMY | Market Share Units | Common Stock, $0.10 par value (23,419) | — | March 10, 2027 | 23,419 | Acquired |
| March 10, 2023 | BMY | Market Share Units | Common Stock, $0.10 par value (4,765) | — | March 10, 2026 | 4,765 | Disposed |
| March 10, 2023 | BMY | Market Share Units | Common Stock, $0.10 par value (4,885) | — | March 10, 2025 | 4,885 | Disposed |
| March 10, 2023 | BMY | Market Share Units | Common Stock, $0.10 par value (4,189) | — | March 10, 2024 | 4,189 | Disposed |
| July 1, 2022 | BMY | Restricted Stock Units | Common Stock, $0.10 par value (9,356) | — | July 1, 2023 | 9,356 | Disposed |
| March 10, 2022 | BMY | Performance Shares | Common Stock, $0.10 par value (28,593) | — | March 10, 2025 | 28,593 | Acquired |
| March 10, 2022 | BMY | Market Share Units | Common Stock, $0.10 par value (19,062) | — | March 10, 2026 | 19,062 | Acquired |
| March 10, 2022 | BMY | Market Share Units | Common Stock, $0.10 par value (4,885) | — | March 10, 2025 | 4,885 | Disposed |
| March 10, 2022 | BMY | Market Share Units | Common Stock, $0.10 par value (4,189) | — | March 10, 2024 | 4,189 | Disposed |
| July 1, 2021 | BMY | Restricted Stock Units | Common Stock, $0.10 par value (9,356) | — | July 1, 2023 | 9,356 | Disposed |
| March 10, 2021 | BMY | Performance Shares | Common Stock, $0.10 par value (29,311) | — | March 10, 2024 | 29,311 | Acquired |
| March 10, 2021 | BMY | Market Share Units | Common Stock, $0.10 par value (19,541) | — | March 10, 2025 | 19,541 | Acquired |
| March 10, 2021 | BMY | Market Share Units | Common Stock, $0.10 par value (4,189) | — | March 10, 2024 | 4,189 | Disposed |
| July 1, 2020 | BMY | Restricted Stock Units | Common Stock, $0.10 par value (9,356) | — | July 1, 2023 | 9,356 | Disposed |
| March 10, 2020 | BMY | Performance Shares | Common Stock, $0.10 par value (25,139) | — | March 10, 2023 | 25,139 | Acquired |
| March 10, 2020 | BMY | Market Share Units | Common Stock, $0.10 par value (16,759) | — | March 10, 2024 | 16,759 | Acquired |
| July 1, 2019 | BMY | Restricted Stock Units | Common Stock, $0.10 par value (37,425) | — | July 1, 2023 | 37,425 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
BMY
M.D.Former EVP, Chief Medical Officer, Head of Development| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $964,904 | $0 | — | — | $928,658 | $0 | $2,625,351 | $10,334,233 |
| 2024 | $1,115,000 | $0 | — | — | $1,564,234 | $0 | $289,018 | $8,586,014 |
| 2023 | $1,103,781 | $0 | $3,616,394 | — | $1,234,117 | $0 | $279,335 | $6,233,627 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.